Statistics

Total Visits

Views
Brigatinib Versus Crizotinib in Advanced ALK Inhibitor-Naive ALK-Positive Non-Small Cell Lung Cancer: Second Interim Analysis of the Phase III ALTA-1L Trial18

File Visits

Downloads
36218-371.pdf8

Select a period of time:

Number of views in the range

Views
Brigatinib Versus Crizotinib in Advanced ALK Inhibitor-Naive ALK-Positive Non-Small Cell Lung Cancer: Second Interim Analysis of the Phase III ALTA-1L Trial12

Number of downloads in the range

Downloads
36218-371.pdf5

Views

Views
December 20230
January 20243
February 20244
March 20240
April 20241
May 20244
June 20240
Download CSV file
 untranslated
 untranslated

Number of downloads in the period of time

  • Downloads
  • December 2023
    0
  • January 2024
    0
  • February 2024
    1
  • March 2024
    1
  • April 2024
    1
  • May 2024
    2
  • June 2024
    0
  • Download CSV file
 untranslated
 untranslated

Top country views

Views
United States11
Spain1
 

Top countries by downloads

Downloads
United States5
 

Top cities views

Views
Boardman3
Chicago2
Fort Worth1
Madrid1
 

Top cities by downloads

Downloads